查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
自測試市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按測試類型、樣本、用途、配銷通路、地區和競爭細分
市場調查報告書
商品編碼
1326473

自測試市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按測試類型、樣本、用途、配銷通路、地區和競爭細分

Self Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Test Type, By Sample, By Usage, By Distribution Channel, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球自我測試市場在預測期內將以驚人的速度成長。由於這些產品的便利性和可獲取性，以及技術的進步使它們更加準確和可靠，該市場變得越來越受歡迎。推動全球自測市場成長的主要因素之一是這些產品提供的便利性和可訪問性。消費者現在可以在舒適的家中監測自己的健康狀況，而無需醫療保健專業人員。對於那些日程繁忙、行動不便或居住在偏遠地區的人來說，這種便利尤其有吸引力。此外，全世界人民的健康意識不斷增強。消費者對自己的健康變得更加積極主動，並正在尋找監測和改善健康的方法。自檢產品提供了一種追踪血糖、膽固醇和血壓等健康指標的便捷方法，可以幫助消費者就自己的健康做出明智的決定。反過來，這預計將支持全球自測市場的成長。

負擔能力

自檢產品往往比傳統醫療保健服務更具成本效益，這也促進了其受歡迎。消費者可以通過在家監測自己的健康狀況來省錢，而不用支付昂貴的醫療檢查或看醫生的費用。此外，部分自檢產品還享受保險，進一步降低了消費者的成本。反過來，預計這將支持未來幾年全球自測試市場的需求。

個性化

由於這些產品提供的個性化功能，全球自測市場在過去幾年中不斷成長。消費者可以從各種滿足其個人需求的自測產品中進行選擇，例如監測血糖水平以進行糖尿病管理或追踪排卵以進行生育計劃。這種個性化使消費者能夠掌控自己的健康，並根據自己的獨特情況做出明智的決定。此外，除了選擇測試的人之外，測試結果也不為其他任何人所知，從而支持了全球自測市場的成長。

慢性病患病率不斷上升

心血管疾病和糖尿病等慢性疾病的日益流行預計將支持自檢市場的成長，直至 2028 年。美國是世界第三大糖尿病人口的所在地。美國約有 3030 萬成年人患有糖尿病，幾乎每 10 名成年人中就有 1 人患有糖尿病。心血管疾病是美國的首要死因，2019 年報告的死亡人數約為 659,041 人。導致心血管疾病的主要因素是糖尿病和高膽固醇。反過來，預計這將增加全球自我檢測市場對血糖檢測和膽固醇檢測部分的需求。

遠程醫療的日益普及

遠程醫療和遠程患者監測的日益普及增加了對家庭檢測套件的需求，從而推動了全球自我診斷市場的成長。遠程醫療的出現使患者轉向家庭診斷，特別是對於需要持續監測血糖水平的糖尿病患者。糖尿病患者使用家用檢測套件在家檢查血糖水平，然後通過電話或影片通話諮詢醫生。這反過來又減少了患者去診所和醫院的需要。不斷成長的糖尿病人口將進一步支持全球自我檢測市場的成長。根據國際糖尿病聯合會的數據，截至 2021 年，大約有 5.37 億成年人（20-79 歲）患有糖尿病。預計到 2030 年，糖尿病患者總數將增至 6.43 億，到 2045 年將增至 7.83 億。

基因檢測

近年來，基因測試也變得越來越廣泛，公司提供的測試可以提供有關廣泛遺傳特徵和健康風險的資訊。這些測試可以在家中進行，並為消費者提供有關其基因構成的個性化資訊。這些資訊可用於就他們的健康和保健做出明智的決定，例如改變生活方式或尋求醫療干涉措施。

近年來，隨著人們尋求更好地了解自己的健康和血統，基因測試變得越來越流行。技術的進步使個人可以線上訂購基因檢測試劑盒並在舒適的家中進行檢測。這些家庭基因檢測產品為人們提供了一種方便且負擔得起的方式來更多地了解他們的基因構成和潛在的健康風險。有許多不同的公司提供家庭使用的基因檢測試劑盒，包括 23andMe、AncestryDNA 和 MyHeritage。這些公司為個人提供簡單的唾液採集套件，他們可以用它來提供 DNA 樣本。然後樣本被送往實驗室進行分析，通常在幾週內即可獲得結果。這些公司提供的測試可以提供有關個人基因構成的大量資訊。例如，他們可以識別與某些疾病風險增加相關的特定遺傳變異，例如帕金森氏症、阿滋海默症和乳腺癌。他們還可以提供有關個人血統和家譜的資訊，這對那些有興趣追踪家族史的人很有幫助。反過來，這有望為全球自測市場的成長創造新的前景。

最近的發展

  • Premom 於 2021 年推出了排卵預測套件，讓女性可以在家追踪自己的生育能力。該套件包括排卵試紙和智慧手機應用程式，可分析結果以提供有關排卵模式和生育狀態的個性化見解。 Premom 排卵預測套件因其準確性和易用性而受到讚譽。
  • Cue Health 於 2020 年推出了可在家進行的快速 COVID-19 檢測。該測試使用鼻拭子和一個連接到智慧手機的緊湊設備，只需 20 分鐘即可提供結果。 Cue Health COVID-19 測試已獲得 FDA 授權緊急使用，並正在學校、工作場所和醫療機構中使用。
  • Ellume, Inc. 於 2020 年推出了可在家進行的快速 COVID-19 測試。該測試使用鼻拭子和小型分析儀，只需 15 分鐘即可得出結果。 Ellume COVID-19 測試已獲得 FDA 授權緊急使用，並正在學校、工作場所和醫療機構中使用。
  • 2019年，23andMe, Inc.推出了健康+祖先服務，為消費者提供有關其遺傳特徵和健康風險的資訊。該服務包括超過 125 份有關健康狀況的報告，例如乳腺癌和心臟病，以及遺傳性疾病的攜帶者狀況。
  • Abbott Laboratories, Inc. 於 2019 年推出了 Libre 2 連續血糖監測 (CGM) 系統。該設備佩戴在上臂背部，提供即時血糖讀數以及高或低血糖水平警報。 Libre 2 還具有藍牙連接功能，允許用戶與醫療保健提供者和護理人員共享血糖數據。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球自測市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按測試類型（血糖測試、妊娠和生育測試、膽固醇測試、尿液測試、COVID-19 測試、其他）
    • 樣本（血液、尿液、唾液）
    • 按用途分類（拋棄式與可重複使用）
    • 按配銷通路（零售店/零售藥店、醫院藥房、大賣場/超市、電子商務管道/網上藥店）
    • 按地區
    • 按公司分類 (2022)
  • 產品圖
    • 按測試類型
    • 按樣品
    • 按用途
    • 按配銷通路
    • 按地區

第 6 章：北美自測市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按測試類型
    • 按樣品
    • 按用途
    • 按配銷通路
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲自測市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按測試類型
    • 按樣品
    • 按用途
    • 按配銷通路
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太自測市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按測試類型
    • 按樣品
    • 按用途
    • 按配銷通路
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美自測市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按測試類型
    • 按樣品
    • 按用途
    • 按配銷通路
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲自測市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按測試類型
    • 按樣品
    • 按用途
    • 按配銷通路
    • 按國家/地區
  • MEA：國家分析
    • 南非自測
    • 沙烏地阿拉伯自測
    • 阿拉伯聯合大公國自測

第 11 章：市場動態

  • 司機
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球自測市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Lucira Health, Inc.
    • Essenlix Corporation
    • Abbott Laboratories, Inc.
    • Quidel Corporation
    • ACON Laboratories, Inc.
    • Scanwell Health, Inc.
    • Johnson & Johnson
    • Geratherm Medical AG
    • B. Braun Holding GmbH
    • OraSure Technologies, Inc.
    • bioLytical Laboratories Inc.
    • Bionime Corporation
    • Becton, Dickinson & Company
    • PRIMA Lab SA
    • F. Hoffmann-La Roche AG

第 16 章：戰略建議

簡介目錄
Product Code: 14871

Global Self Testing Market is expected to grow at an impressive rate during the forecast period. This market has become increasingly popular due to the convenience and accessibility of these products, as well as advances in technology that have made them more accurate and reliable. One of the primary factors driving the growth of the global self-testing market is the convenience and accessibility that these products offer. Consumers can now monitor their health from the comfort of their own homes without the need for a healthcare professional. This convenience is particularly attractive for those with busy schedules, mobility issues, or who live in remote areas. Additionally, the increasing awareness of health and wellness among the population worldwide. Consumers are becoming more proactive about their health and are seeking out ways to monitor and improve their well-being. Self-testing products provide a convenient way to track health indicators such as blood sugar, cholesterol, and blood pressure, which can help consumers make informed decisions about their health. This, in turn, is expected to support the growth of global self-testing market.

Affordability

Self-testing products are often more cost-effective than traditional healthcare services, which has also contributed to their popularity. Consumers can save money by monitoring their health at home instead of paying for expensive medical tests or doctor's visits. Additionally, some self-testing products are covered by insurance, which further reduces costs for consumers. This, in turn, is expected to support the demand for global self-testing market in the coming years.

Personalization

Global self-testing market has grown over the last few years due to the personalization that these products offer. Consumers can choose from a wide range of self-testing products that cater to their individual needs, such as monitoring blood sugar levels for diabetes management or tracking ovulation for fertility planning. This personalization allows consumers to take control of their health and make informed decisions based on their unique circumstances. Additionally, the test results are also not known to anyone else except the one opting for the test, thereby supporting the growth of global self-testing market.

The self-testing kits are highly useful in fertility testing. Home testing kits can provide information on ovulation and fertility status, enabling women to plan their families and make informed decisions about their reproductive health. Fertility testing has traditionally been performed in a clinical setting, but new products have made it possible for women to test their fertility at home. This, in turn, is expected to drive the growth of global self-testing market.

Growing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases such as cardiovascular diseases and diabetes is expected to support the self-testing market growth through 2028. The United States is home to the world's third-largest diabetic population. Around 30.3 million adults in the United States are suffering from diabetes which is almost 1 in 10 adults. Cardiovascular diseases are the leading cause of death in the United States, with around 659,041 reported deaths in 2019. The major factors contributing to cardiovascular diseases are diabetes and high cholesterol. This, in turn, is expected to increase the demand for blood glucose testing and cholesterol testing segment of global self-testing market.

Growing Adoption of Telemedicine

The growing adoption of telemedicine and remote patient monitoring increased the demand for at-home testing kits, thereby driving the growth of global self-diagnostics market. The advent of telemedicine made patients switch to at-home diagnostics, especially in the case of patients suffering from diabetes who continuously need to monitor their blood glucose levels. Diabetic patients using at-home testing kits check their blood glucose levels at home and then consult their doctor over the phone or video call. This, in turn, has reduced the need for patients to visit clinics and hospitals. The growing diabetic population will further support the growth of global self-testing market. According to International Diabetes Federation, as of 2021, Approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

Genetic Testing

Genetic testing has also become more widely available in recent years, with companies offering tests that can provide information on a wide range of genetic traits and health risks. These tests can be performed at home and provide consumers with personalized information on their genetic makeup. This information can be used to make informed decisions about their health and wellness, such as making lifestyle changes or seeking out medical interventions.

Genetic testing has become increasingly popular in recent years as people seek to better understand their health and ancestry. Advances in technology have made it possible for individuals to order genetic testing kits online and perform the tests in the comfort of their own homes. These at-home genetic testing products provide people with a convenient and affordable way to learn more about their genetic makeup and potential health risks. There are many different companies that offer genetic testing kits for use at home, including 23andMe, AncestryDNA, and MyHeritage. These companies provide individuals with a simple saliva collection kit that they can use to provide a DNA sample. The samples are then sent to a laboratory for analysis, and the results are usually available within a few weeks. The tests offered by these companies can provide a wealth of information about an individual's genetic makeup. For example, they can identify specific genetic variants that are associated with an increased risk of certain diseases, such as Parkinson's disease, Alzheimer's disease, and breast cancer. They can also provide information about an individual's ancestry and genealogy, which can be helpful for those interested in tracing their family history. This, in turn, is expected to create new prospects for the growth of global self-testing market.

Market Segmentation

Global Self Testing Market can be segmented by test type, sample, usage, distribution channel, and region. Based on test type, the global self-testing market can be categorized into blood glucose testing, pregnancy & fertility testing, cholesterol testing, urine testing, COVID-19 testing, and others. By sample, the global self-testing market can be categorized into blood, urine, and saliva. By usage, the global self-testing market can be split into disposable and reusable. In terms of distribution channels, the global self-testing market can be segmented into retail stores/retail pharmacies, hospital pharmacies, hypermarkets/supermarket, and e-commerce channels/online pharmacies. Regionally, the global self testing market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Lucira Health, Inc., Essenlix Corporation, Abbott Laboratories, Inc., Quidel Corporation, ACON Laboratories, Inc., Scanwell Health, Inc., Johnson & Johnson, Geratherm Medical AG, B. Braun Holding GmbH, OraSure Technologies, Inc., bioLytical Laboratories Inc., Bionime Corporation, Becton, Dickinson & Company, PRIMA Lab SA, F. Hoffmann-La Roche AG, among others are some of the leading players operating in the global Self Testing market.

Recent Developments

  • Premom launched its ovulation prediction kit in 2021, which allows women to track their fertility at home. The kit includes ovulation test strips and a smartphone app that analyzes the results to provide personalized insights into ovulation patterns and fertility status. The Premom ovulation prediction kit has been praised for its accuracy and ease of use.
  • Cue Health launched a rapid COVID-19 test in 2020 that can be performed at home. The test uses a nasal swab and a compact device that connects to a smartphone to provide results in just 20 minutes. The Cue Health COVID-19 test has been authorized by the FDA for emergency use and is being used in schools, workplaces, and healthcare settings.
  • Ellume, Inc. launched a rapid COVID-19 test in 2020 that can be performed at home. The test uses a nasal swab and a small analyzer device that provides results in just 15 minutes. The Ellume COVID-19 test has been authorized by the FDA for emergency use and is being used in schools, workplaces, and healthcare settings.
  • In 2019, 23andMe, Inc. launched its Health + Ancestry service, which provides consumers with information on their genetic traits and health risks. The service includes more than 125 reports on health conditions, such as breast cancer and heart disease, as well as carrier status for inherited conditions.
  • Abbott Laboratories, Inc. launched the Libre 2 continuous glucose monitoring (CGM) system in 2019. The device is worn on the back of the upper arm and provides real-time glucose readings and alerts for high or low blood sugar levels. The Libre 2 also has Bluetooth connectivity, allowing users to share their glucose data with healthcare providers and caregivers.

Report Scope:

In this report, Global Self Testing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Self Testing Market, By Test Type:

  • Blood Glucose Testing
  • Pregnancy & Fertility Testing
  • Cholesterol Testing
  • Urine Testing
  • COVID-19 Testing
  • Others

Self Testing Market, By Sample:

  • Blood
  • Urine
  • Saliva

Self-Testing Market, By Usage:

  • Disposable
  • Reusable

Self-Testing Market, By Distribution Channel:

  • Retail Stores/Retail Pharmacies
  • Hospital Pharmacies
  • Hypermarket/Supermarket
  • E-Commerce Channels/Online Pharmacies

Self-Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Self Testing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Self Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others)
    • 5.2.2. By Sample (Blood, Urine, Saliva)
    • 5.2.3. By Usage (Disposable v/s Reusable)
    • 5.2.4. By Distribution Channel (Retail Stores/Retail Pharmacies, Hospital Pharmacies, Hypermarket/Supermarket, E-Commerce Channels/Online Pharmacies)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Test Type
    • 5.3.2. By Sample
    • 5.3.3. By Usage
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. North America Self Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Sample
    • 6.2.3. By Usage
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Self Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Sample
        • 6.3.1.2.3. By Usage
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Self Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Sample
        • 6.3.2.2.3. By Usage
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Self Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Sample
        • 6.3.3.2.3. By Usage
        • 6.3.3.2.4. By Distribution Channel

7. Europe Self Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Sample
    • 7.2.3. By Usage
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Self Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Usage
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Germany Self Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Usage
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Self Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Usage
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Self Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Sample
        • 7.3.4.2.3. By Usage
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Self Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Sample
        • 7.3.5.2.3. By Usage
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Self Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Sample
    • 8.2.3. By Usage
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Self Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Usage
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Self Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Usage
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Japan Self Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Usage
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. South Korea Self Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Usage
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Self Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Usage
        • 8.3.5.2.4. By Distribution Channel

9. South America Self Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Sample
    • 9.2.3. By Usage
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Self Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Usage
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Self Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Usage
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Self Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Usage
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Self Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Sample
    • 10.2.3. By Usage
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Self Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Usage
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Self Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Usage
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Self Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Usage
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Self Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Lucira Health, Inc.
    • 15.5.2. Essenlix Corporation
    • 15.5.3. Abbott Laboratories, Inc.
    • 15.5.4. Quidel Corporation
    • 15.5.5. ACON Laboratories, Inc.
    • 15.5.6. Scanwell Health, Inc.
    • 15.5.7. Johnson & Johnson
    • 15.5.8. Geratherm Medical AG
    • 15.5.9. B. Braun Holding GmbH
    • 15.5.10. OraSure Technologies, Inc.
    • 15.5.11. bioLytical Laboratories Inc.
    • 15.5.12. Bionime Corporation
    • 15.5.13. Becton, Dickinson & Company
    • 15.5.14. PRIMA Lab SA
    • 15.5.15. F. Hoffmann-La Roche AG

16. Strategic Recommendations